Essilor International, the French ophthalmic optics company that designs, manufactures and distributes lenses, was fined by the French Competition Authority (FCA). The company will have to shell out €81 million to settle the penalty with the antitrust regulators in France.
According to Reuters, the FCA handed down its decision to Essilor for alleged unfair business practices. The competition watchdog said that the fine was for the violations that stretch over 11 years.
The authorities explained this week that optic lens maker’s actions had been mapped out to impede the development of online sales for corrective lenses in France. EssilorLuxottica, Essilor’s parent company, will pay €15 million out of the total penalty of €81 million.
The Autorite de la Concurrence said EssilorLuxottica and its Essilor International engaged in practices that blocked online sales of some prescription lenses in the country. The antitrust regulator determined that Essilor abused its dominant position in the lenses distribution market this move has become an obstruction in the growth of online sales of other eye-corrective lens and eyeglasses firms such as DirectOptic, Sensee, and Happyview.
Market Watch reported that as early as 2009, Essilor prevented some online platforms from selling its Essilor or Varilux optic lenses to customers. The authorities added the company refused to deliver its branded lenses as well while also barring the websites from displaying the Essilor logo and trademark. This practice continued for more than a decade, which is why the FCA imposed a hefty fine.
Meanwhile, in a press release, EssilorLuxottica said it is challenging the decision of the FCA. The revealed its intention to file an appeal as it strongly disagrees with the regulators’ decision.
“EssilorLuxottica acknowledges that the French competition authority (FCA) has published today a decision concerning Essilor International,” the French-Italian Ray-Ban manufacturer said. “EssilorLuxottica firmly believes in the legality of its practices and in the relevancy of distributing specific segments of prescription products under conditions that enable us to ensure that consumers can get the best vision correction that is required by their individual vision needs.”
EssilorLuxottica further reiterated that its business practices were fully compliant with the competitive and regulatory conditions in the mentioned period. For its appeal, the firm is confident that it will be able to prove that the FCA’s decision is groundless.


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Dollar Holds Firm Ahead of Global Central Bank Decisions as Yen, Sterling and Euro React
BOJ Poised for Historic Rate Hike as Japan Signals Shift Toward Monetary Normalization
Oil Prices Climb on Venezuela Blockade, Russia Sanctions Fears, and Supply Risks
U.S. Stock Futures Edge Higher as Micron Earnings Boost AI Sentiment Ahead of CPI Data
BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited
South Korea Warns Weak Won Could Push Inflation Higher in 2025
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns
U.S. Stock Futures Slip After CPI-Fueled Rally as Markets Weigh Economic Uncertainty
Kevin Hassett Says Inflation Is Below Target, Backs Trump’s Call for Rate Cuts
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



